生命科学资讯

JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study

Amgen dances with Disco in $618M cancer target pact

Cancer biotech Disco lines up Amgen as first pharma partner

Amgen buys protein-degrading startup Dark Blue for up to $840M

Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs

Amgen to acquire Dark Blue Therapeutics for up to $840M

FDA broadens label for Amgen's Uplizna as it enters rare disease competition

Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx

Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO

Amgen describes new GTPase KRAS mutant inhibitors

Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire

Cytiva Subsidiary Seeks to Quash Subpoena Issued in Amgen’s US Denosumab Litigation Against Accord & Intas - Pearce IP